Found 458 matching trials
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Jonsson Comprehensive Cancer Center, UCLA
Learn More & Join Trial
Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide) PHASE2 This study aims to investigate the efficacy and safety of PET regimen combi...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial
A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus PHASE2 The purpose of this double-masked, pilot trial is to determine whether 20 p...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma PHASE2 Study Objectives
1. Evaluate the efficacy of the combination of thalidomid...
Show More Location
Weill Medical College of Cornell University
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus PHASE2 This phase II trial is studying how well thalidomide works in treating pati...
Show More Location
Gynecologic Oncology Group
Learn More & Join Trial
The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients PHASE3 Both malnutrition and inflammation are associated with death in dialysis pa...
Show More Location
Beth Israel Medical Center
Learn More & Join Trial
Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia PHASE2 Phase II trial to study the effectiveness of thalidomide in treating patien...
Show More Location
North Central Cancer Treatment Group
Learn More & Join Trial
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years PHASE3 This protocol is an international, multicenter, comparative, open and rando...
Show More Location
Hospital Universitário Clementino Fraga Filho
Learn More & Join Trial
A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation PHASE2 The primary purpose of this study is to determine the overall response rate...
Show More Location
CEHON Centro de Hematologia e Oncologia da Bahia
Learn More & Join Trial